These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 850244)

  • 1. Quantitative structure-activity relationships of chymotrypsin. On the predictive value of correlation equations.
    Grieco C; Silipo C; Vittoria A; Hansch C
    J Med Chem; 1977 Apr; 20(4):586-8. PubMed ID: 850244
    [No Abstract]   [Full Text] [Related]  

  • 2. The binding of boronic acids to chymotrypsin.
    Rawn JD; Lienhard GE
    Biochemistry; 1974 Jul; 13(15):3124-30. PubMed ID: 4858346
    [No Abstract]   [Full Text] [Related]  

  • 3. Parabolic hydrophobic inhibition of alpha-chymotrypsin.
    Smith BN; Hansch C; Poindexter TP
    Physiol Chem Phys; 1974; 6(4):323-31. PubMed ID: 4457934
    [No Abstract]   [Full Text] [Related]  

  • 4. [Interaction of alpha-chymotrypsin with tripeptide substrates and inhibitors].
    D'iachenko ED; Volkova LI; Kozlov LV; Antonov VK
    Mol Biol; 1974; 8(6):879-85. PubMed ID: 4469591
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptide aldehydes inhibiting chymotrypsin.
    Ito A; Tokawa K; Shimizu B
    Biochem Biophys Res Commun; 1972 Oct; 49(2):343-9. PubMed ID: 4640362
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydrophobic interaction of small molecules with alpha-chymotrypsin.
    Smith RN; Hansch C
    Biochemistry; 1973 Nov; 12(24):4924-37. PubMed ID: 4761974
    [No Abstract]   [Full Text] [Related]  

  • 7. Guanidination of lysine-15 in the active site of the basic pancreatic trypsin inhibitor. Implications for complex formation with trypsin and chymotrypsin.
    Vincent JP; Schweitz H; Lazdunski M
    Eur J Biochem; 1974 Mar; 42(2):505-10. PubMed ID: 4857287
    [No Abstract]   [Full Text] [Related]  

  • 8. The binding of specific and non-specific aldehyde substrate analogs to alpha-chymotrypsin.
    Breaux EJ; Bender ML
    FEBS Lett; 1975 Aug; 56(1):81-4. PubMed ID: 239865
    [No Abstract]   [Full Text] [Related]  

  • 9. Alpha-chymotrypsin: a case study of substituent constants and regression analysis in enzymic structure--activity relationships.
    Hansch C; Coats E
    J Pharm Sci; 1970 Jun; 59(6):731-43. PubMed ID: 4912447
    [No Abstract]   [Full Text] [Related]  

  • 10. Halo enol lactone inhibitors of chymotrypsin: burst kinetics and enantioselectivity of inactivation.
    Baek DJ; Katzenellenbogen JA
    Biochem Biophys Res Commun; 1991 Aug; 178(3):1335-42. PubMed ID: 1872851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A mechanistic study on the inhibition of α-chymotrypsin by a macrocyclic peptidomimetic aldehyde.
    Zhang X; Bruning JB; George JH; Abell AD
    Org Biomol Chem; 2016 Aug; 14(29):6970-8. PubMed ID: 27349772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics and thermodynamics of the slow hydrophobic deactivation of alpha-chymotrypsin.
    Smith RN; Poindexter TP; Hansch C
    Physiol Chem Phys; 1975; 7(5):423-36. PubMed ID: 1197384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the correlation between three-dimensional structure and reactivity for a series of locked substrates of chymotrypsin.
    Rodgers PS; Goaman LC; Blow DM
    J Am Chem Soc; 1976 Oct; 98(21):6690-5. PubMed ID: 972222
    [No Abstract]   [Full Text] [Related]  

  • 14. The topographical differences in the active site region of alpha-chymotrypsin, subtilisin Novo, and subtilisin Carlsberg. Mapping the aromatic binding site by inhibitors (virtual substrates).
    Bosshard HR; Berger A
    Biochemistry; 1974 Jan; 13(2):266-77. PubMed ID: 4810052
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration of the acyl-enzyme mechanism for the hydrolysis of peptides and anilides by chymotrypsin.
    Fastrez J; Fersht AR
    Biochemistry; 1973 May; 12(11):2025-34. PubMed ID: 4705984
    [No Abstract]   [Full Text] [Related]  

  • 16. Halo enol lactones: studies on the mechanism of inactivation of alpha-chymotrypsin.
    Daniels SB; Katzenellenbogen JA
    Biochemistry; 1986 Mar; 25(6):1436-44. PubMed ID: 3964685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of chymotrypsin. Structure, reactivity, and nonproductive binding relationships.
    Fastrez J; Fersht AR
    Biochemistry; 1973 Mar; 12(6):1067-74. PubMed ID: 4688860
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, structure-activity relationships studies of benzoxazinone derivatives as α-chymotrypsin inhibitors.
    Marasini BP; Rahim F; Perveen S; Karim A; Mohammed Khan K; Atta-Ur-Rahman ; Choudhary MI
    Bioorg Chem; 2017 Feb; 70():210-221. PubMed ID: 28087168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetics studies on the lignan class of natural compounds that inhibits alpha-chymotrypsin.
    Abbasi MA; Lodhi MA; Ahmad VU; Choudhary MI
    J Asian Nat Prod Res; 2009 Nov; 11(11):933-9. PubMed ID: 20183256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of chymotrypsin by alkyl phosphonates: a quantitative structure-activity analysis.
    Silipo C; Hansch C; Grieco C; Vittoria A
    Arch Biochem Biophys; 1979 May; 194(2):552-7. PubMed ID: 443820
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.